India pharma exports soaring despite cough syrup deaths, trade body says | Reuters News Agency

[ad_1]

Health

Reuters exclusively reported that India’s pharmaceutical exports this fiscal year are set to grow nearly twice as fast as last year to hit sales of $27 billion, driven by strong U.S. buying, a government-backed trade body told Reuters, despite deaths linked to Indian-made cough syrups. 

Market Impact

India’s pharmaceutical exports this fiscal year are set to grow nearly twice as fast as last year to hit sales of $27 billion, driven by strong U.S. buying, despite deaths linked to Indian-made cough syrups. India is the world’s third largest maker of drugs by volume after the United States and China. 

Article Tags

Topics of Interest: Health

Sectors: Pharmaceuticals & Healthcare

Regions: Asia

Countries: India

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *